Patents by Inventor Stephanie J. Yaung

Stephanie J. Yaung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF CANCER PROGNOSIS BY ASSESSING TUMOR VARIANT DIVERSITY
    Publication number: 20210222251
    Abstract: The invention is a method of predicting response to therapy in a colorectal cancer patient, the method comprising measuring tumor genetic heterogeneity via analysis of circulating tumor DNA from a patient's sample.
    Type: Application
    Filed: May 8, 2019
    Publication date: July 22, 2021
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Aarthi BALASUBRAMANYAM, Felix HERTH, Christine JU, Xiaoju MA, Thomas MULEY, Birgit WEHNL, Liu XI, Stephanie J. YAUNG
  • SURROGATE MARKER AND METHOD FOR TUMOR MUTATION BURDEN MEASUREMENT
    Publication number: 20210054465
    Abstract: The invention is a method of predicting recurrence of colorectal cancer in a patient following surgery, the method comprising analysis of circulating tumor DNA from a patient's sample.
    Type: Application
    Filed: May 3, 2019
    Publication date: February 25, 2021
    Inventors: Aarthi Balasubramanyam, Christine Ju, Xiaoju Ma, Thomas Muley, Felix Herth, Nalin Tikoo, Birgit Wehnl, Liu Xi, Stephanie J. Yaung, Amrita Pati
  • METHOD OF PREDICTING RESPONSE TO THERAPY BY ASSESSING TUMOR GENETIC HETEROGENEITY
    Publication number: 20210002719
    Abstract: The invention is a method of predicting response to therapy in a colorectal cancer patient, the method comprising measuring tumor genetic heterogeneity via analysis of circulating tumor DNA from a patient's sample.
    Type: Application
    Filed: February 11, 2019
    Publication date: January 7, 2021
    Inventors: Fergal Casey, John J. Lee, John F. Palma, Stephanie J. Yaung
  • METHOD OF PREDICTING RESPONSE TO THERAPY BY ASSESSING TUMOR GENETIC HETEROGENEITY
    Publication number: 20200399711
    Abstract: The invention is a method of predicting response to therapy in a cancer patient by serial sampling the patient's cell-free tumor nucleic acids to determine a change in the number of mutations per amount of plasma.
    Type: Application
    Filed: February 11, 2019
    Publication date: December 24, 2020
    Inventors: Aarthi Balasubramanyam, Christine Ju, Xiaoju Ma, Thomas Muley, Felix Herth, Nalin Tikoo, Birgit Wehnl, Liu Xi, Stephanie J. Yaung